Sudarshan Chemical Industries
Sudarshan Chemical reported a tough Q3 FY26, with the acquired Heubach/Clariant business posting a €38 million EBITDA loss, driven by customer destocking and weak demand in Europe and North America.
Side-by-side earnings comparison across verified financials, sentiment, risks, and management commentary.
Sudarshan Chemical reported a tough Q3 FY26, with the acquired Heubach/Clariant business posting a €38 million EBITDA loss, driven by customer destocking and weak demand in Europe and North America.
Fineotex Chemical delivered a strong Q3 FY26 with revenue surging 46% YoY to ₹190 crore, driven by the acquisition of Crude Chem Technology (CCT) and improving demand in textiles and oil & gas.
We expect a 9 to 10 million of a business EBITDA right however we are in a mode now to start reducing our inventories... and that would have an impact on our EBITDA going forward but it will have a very positive impact on cash flow.
This acquisition is fully aligned with our communicated growth plan and a long-term strategy of expanding into technology-driven specialty segments.